Pharmacologic pain treatment of musculoskeletal disorders: Current perspectives and future prospects

被引:63
作者
Curatolo, M
Bogduk, N
机构
[1] Univ Hosp Bern, Dept Anesthesiol, Div Pain Therapy, CH-3010 Bern, Switzerland
[2] Univ Newcastle, Bone & Joint Inst, Newcastle, NSW 2308, Australia
关键词
drug therapy; musculoskeletal pain;
D O I
10.1097/00002508-200103000-00005
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: The authors aimed to provide an educational update on the current evidence of the effectiveness of drug therapy in the treatment of musculoskeletal pain and to offer a perspective of possible future developments. Design: The authors used a pragmatic review of data provided by available systematic reviews and seminal controlled studies pertaining to the treatment of regional musculoskeletal pain problems. Results: Epidural steroids may offer limited, short-term benefit for sciatica. Local injections of steroids are either ineffective or provide short-lasting benefits. Nonsteroidal anti-inflammatory drugs and opioids reduce pain, but the effect size is modest. The literature does not support convincingly the use of antidepressants. Certain muscle relaxants may be useful in the treatment of back pain. Hyaluronic acid, neutraceutical agents, avocado-soybean unsaponifiable agents, oxaceprol and diacerein may be effective in the treatment of osteoarthritis, but the information regarding these new agents does not allow wholesale endorsement of these substances. Selective epidural injection of steroids at a target nerve root approached through the intervertebral foramin has the potential to replace the traditional epidural approach. Long-acting, C-fiber-specific local anesthetics are under investigation and could provide long-lasting pain relief without motor or sensory impairment. In the future, central hypersensitivity in chronic musculoskeletal pain might be treated using antagonists of the N-methyl-D-aspartate receptor. Cannabinoid agents produce antinociception and prevent experimentally induced hyperalgesia in animals, and they may find a role in pain management. Methods to optimize drug combinations are available. Conclusions: The effectiveness of the currently available drugs in the treatment of musculoskeletal pain conditions is disappointing. Recent developments may open new perspectives in this area of pain medicine.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 87 条
[1]  
Aker PD, 1996, BMJ-BRIT MED J, V313, P1291
[2]   A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons [J].
Akopian, AN ;
Sivilotti, L ;
Wood, JN .
NATURE, 1996, 379 (6562) :257-262
[3]  
ALCOFF J, 1982, J FAM PRACTICE, V14, P841
[4]   Musculoskeletal chronic pain in general practice -: Studies of health care utilisation in comparison with pain prevalence [J].
Andersson, HI ;
Ejlertsson, G ;
Leden, I ;
Scherstén, B .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 1999, 17 (02) :87-92
[5]  
[Anonymous], MAN MED
[6]  
[Anonymous], 1999, Epidemiology of pain
[7]  
[Anonymous], 1976, ADV PAIN RES THERAPY
[8]  
Assendelft WJJ, 1996, BRIT J GEN PRACT, V46, P209
[9]   Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity [J].
Atkinson, JH ;
Slater, MA ;
Wahlgren, DR ;
Williams, RA ;
Zisook, S ;
Pruitt, SD ;
Epping-Jordan, JE ;
Patterson, TL ;
Grant, I ;
Abramson, I ;
Garfin, SR .
PAIN, 1999, 83 (02) :137-145
[10]   A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain [J].
Atkinson, JH ;
Slater, MA ;
Williams, RA ;
Zisook, S ;
Patterson, TL ;
Grant, I ;
Wahlgren, DR ;
Abramson, I ;
Garfin, SR .
PAIN, 1998, 76 (03) :287-296